{"entity":{"type":"insider","cik":"0001645333","url":"/insider/0001645333","json_url":"/insider/0001645333.json","name":"Column Group II GP, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":203,"n_filings":75,"first":"2016-09-22","last":"2023-11-17","span_basis":"filed_date"},"name_variants":[{"name":"Column Group II GP, LP","source":"filing","n_filings":75,"first_seen":"2016-09-22","last_seen":"2023-11-17"}],"transactions":[{"id":8750030,"accession":"0000950170-23-064847","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-064847","line_url":"/filing/0000950170-23-064847#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP II, LP; COLUMN GROUP L P; Column Group II GP, LP; Column Group Management LP; Kutzkey Tim; PONOI CAPITAL, LP; Ponoi Capital II, LP; Ponoi II Management, LLC; Ponoi Management, LLC; Svennilson Peter","owner_display_name":"COLUMN GROUP II, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5840.0,"shares_display":"5,840","price_per_share":0.6211,"price_display":"0.62","price_state":"stated","total_value":3627.224,"total_display":"3,627.22","total_whole":"3,627","shares_owned_after":949862.0,"shares_owned_after_display":"949,862","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-17","scope":"insider"},{"id":8750026,"accession":"0000950170-23-064847","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-064847","line_url":"/filing/0000950170-23-064847#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP II, LP; COLUMN GROUP L P; Column Group II GP, LP; Column Group Management LP; Kutzkey Tim; PONOI CAPITAL, LP; Ponoi Capital II, LP; Ponoi II Management, LLC; Ponoi Management, LLC; Svennilson Peter","owner_display_name":"COLUMN GROUP II, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16791.0,"shares_display":"16,791","price_per_share":0.7075,"price_display":"0.71","price_state":"stated","total_value":11879.6325,"total_display":"11,879.63","total_whole":"11,880","shares_owned_after":944022.0,"shares_owned_after_display":"944,022","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":8010048,"accession":"0000899243-23-003130","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-003130","line_url":"/filing/0000899243-23-003130#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Ponoi Capital II, LP; PONOI CAPITAL, LP; Column Group II GP, LP; Column Group Management LP; COLUMN GROUP II, LP; Svennilson Peter; COLUMN GROUP L P; Ponoi Management, LLC; Kutzkey Tim; Ponoi II Management, LLC","owner_display_name":"Ponoi Capital II, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":176730.0,"shares_display":"176,730","price_per_share":4.9986,"price_display":"5.00","price_state":"stated","total_value":883402.578,"total_display":"883,402.58","total_whole":"883,403","shares_owned_after":927231.0,"shares_owned_after_display":"927,231","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-01","scope":"insider"},{"id":8010044,"accession":"0000899243-23-003130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-003130","line_url":"/filing/0000899243-23-003130#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Ponoi Capital II, LP; PONOI CAPITAL, LP; Column Group II GP, LP; Column Group Management LP; COLUMN GROUP II, LP; Svennilson Peter; COLUMN GROUP L P; Ponoi Management, LLC; Kutzkey Tim; Ponoi II Management, LLC","owner_display_name":"Ponoi Capital II, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7542.0,"shares_display":"7,542","price_per_share":4.9996,"price_display":"5.00","price_state":"stated","total_value":37706.9832,"total_display":"37,706.98","total_whole":"37,707","shares_owned_after":750501.0,"shares_owned_after_display":"750,501","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-02-01","scope":"insider"},{"id":8279106,"accession":"0000899243-23-002630","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002630","line_url":"/filing/0000899243-23-002630#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Ponoi II Management, LLC; Svennilson Peter; Column Group Management LP; COLUMN GROUP L P; Ponoi Management, LLC; Column Group II GP, LP; PONOI CAPITAL, LP; Kutzkey Tim; Ponoi Capital II, LP; COLUMN GROUP II, LP","owner_display_name":"Ponoi II Management, LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9900.0,"shares_display":"9,900","price_per_share":4.9994,"price_display":"5.00","price_state":"stated","total_value":49494.06,"total_display":"49,494.06","total_whole":"49,494","shares_owned_after":742959.0,"shares_owned_after_display":"742,959","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-25","scope":"insider"},{"id":8644229,"accession":"0000899243-23-002375","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-002375","line_url":"/filing/0000899243-23-002375#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Ponoi Management, LLC; PONOI CAPITAL, LP; Column Group II GP, LP; Svennilson Peter; Column Group Management LP; Ponoi II Management, LLC; Ponoi Capital II, LP; COLUMN GROUP L P; Kutzkey Tim; COLUMN GROUP II, LP","owner_display_name":"Ponoi Management, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":4.996,"price_display":"5.00","price_state":"stated","total_value":2498.0,"total_display":"2,498.00","total_whole":"2,498","shares_owned_after":733059.0,"shares_owned_after_display":"733,059","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-20","filed_date":"2023-01-23","scope":"insider"},{"id":8644226,"accession":"0000899243-23-002375","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002375","line_url":"/filing/0000899243-23-002375#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Ponoi Management, LLC; PONOI CAPITAL, LP; Column Group II GP, LP; Svennilson Peter; Column Group Management LP; Ponoi II Management, LLC; Ponoi Capital II, LP; COLUMN GROUP L P; Kutzkey Tim; COLUMN GROUP II, LP","owner_display_name":"Ponoi Management, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":37639.0,"shares_display":"37,639","price_per_share":4.9976,"price_display":"5.00","price_state":"stated","total_value":188104.6664,"total_display":"188,104.67","total_whole":"188,105","shares_owned_after":732559.0,"shares_owned_after_display":"732,559","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-19","filed_date":"2023-01-23","scope":"insider"},{"id":8619898,"accession":"0000899243-23-001854","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-001854","line_url":"/filing/0000899243-23-001854#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Svennilson Peter; Column Group II GP, LP; Ponoi Management, LLC; Ponoi II Management, LLC; COLUMN GROUP L P; Column Group Management LP; Ponoi Capital II, LP; Kutzkey Tim; COLUMN GROUP II, LP; PONOI CAPITAL, LP","owner_display_name":"Svennilson Peter","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5378.0,"shares_display":"5,378","price_per_share":4.9466,"price_display":"4.95","price_state":"stated","total_value":26602.8148,"total_display":"26,602.81","total_whole":"26,603","shares_owned_after":694920.0,"shares_owned_after_display":"694,920","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-12","filed_date":"2023-01-17","scope":"insider"},{"id":8527664,"accession":"0000899243-23-001694","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-001694","line_url":"/filing/0000899243-23-001694#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Ponoi Management, LLC; PONOI CAPITAL, LP; Column Group II GP, LP; Svennilson Peter; Column Group Management LP; Ponoi II Management, LLC; Ponoi Capital II, LP; COLUMN GROUP L P; Kutzkey Tim; COLUMN GROUP II, LP","owner_display_name":"Ponoi Management, LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":209000.0,"shares_display":"209,000","price_per_share":4.76,"price_display":"4.76","price_state":"stated","total_value":994840.0,"total_display":"994,840.00","total_whole":"994,840","shares_owned_after":689542.0,"shares_owned_after_display":"689,542","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-11","filed_date":"2023-01-12","scope":"insider"},{"id":8527658,"accession":"0000899243-23-001694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-001694","line_url":"/filing/0000899243-23-001694#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Ponoi Management, LLC; PONOI CAPITAL, LP; Column Group II GP, LP; Svennilson Peter; Column Group Management LP; Ponoi II Management, LLC; Ponoi Capital II, LP; COLUMN GROUP L P; Kutzkey Tim; COLUMN GROUP II, LP","owner_display_name":"Ponoi Management, LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100070.0,"shares_display":"100,070","price_per_share":4.8418,"price_display":"4.84","price_state":"stated","total_value":484518.926,"total_display":"484,518.93","total_whole":"484,519","shares_owned_after":480542.0,"shares_owned_after_display":"480,542","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-10","filed_date":"2023-01-12","scope":"insider"},{"id":6805069,"accession":"0000899243-22-038465","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-038465","line_url":"/filing/0000899243-22-038465#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"PONOI CAPITAL, LP; COLUMN GROUP II, LP; Ponoi II Management, LLC; Kutzkey Tim; Ponoi Management, LLC; Svennilson Peter; Column Group II GP, LP; Column Group Management LP; Ponoi Capital II, LP; COLUMN GROUP L P","owner_display_name":"PONOI CAPITAL, LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":4.9767,"price_display":"4.98","price_state":"stated","total_value":1493.01,"total_display":"1,493.01","total_whole":"1,493","shares_owned_after":380472.0,"shares_owned_after_display":"380,472","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-12","filed_date":"2022-12-14","scope":"insider"},{"id":6118189,"accession":"0000899243-22-036912","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-036912","line_url":"/filing/0000899243-22-036912#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP II, LP; Ponoi II Management, LLC; Ponoi Capital II, LP; COLUMN GROUP L P; PONOI CAPITAL, LP; Svennilson Peter; Ponoi Management, LLC; Kutzkey Tim; Column Group Management LP; Column Group II GP, LP","owner_display_name":"COLUMN GROUP II, LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4330.0,"shares_display":"4,330","price_per_share":4.9991,"price_display":"5.00","price_state":"stated","total_value":21646.103,"total_display":"21,646.10","total_whole":"21,646","shares_owned_after":380172.0,"shares_owned_after_display":"380,172","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-22","filed_date":"2022-11-23","scope":"insider"},{"id":6118184,"accession":"0000899243-22-036912","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-036912","line_url":"/filing/0000899243-22-036912#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP II, LP; Ponoi II Management, LLC; Ponoi Capital II, LP; COLUMN GROUP L P; PONOI CAPITAL, LP; Svennilson Peter; Ponoi Management, LLC; Kutzkey Tim; Column Group Management LP; Column Group II GP, LP","owner_display_name":"COLUMN GROUP II, LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35997.0,"shares_display":"35,997","price_per_share":4.9988,"price_display":"5.00","price_state":"stated","total_value":179941.8036,"total_display":"179,941.80","total_whole":"179,942","shares_owned_after":375842.0,"shares_owned_after_display":"375,842","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-23","scope":"insider"},{"id":6841747,"accession":"0000899243-22-035274","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-035274","line_url":"/filing/0000899243-22-035274#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Kutzkey Tim; Ponoi Management, LLC; COLUMN GROUP II, LP; Svennilson Peter; PONOI CAPITAL, LP; COLUMN GROUP L P; Ponoi Capital II, LP; Ponoi II Management, LLC; Column Group Management LP; Column Group II GP, LP","owner_display_name":"Kutzkey Tim","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35058.0,"shares_display":"35,058","price_per_share":4.7156,"price_display":"4.72","price_state":"stated","total_value":165319.5048,"total_display":"165,319.50","total_whole":"165,320","shares_owned_after":339845.0,"shares_owned_after_display":"339,845","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-04","filed_date":"2022-11-07","scope":"insider"},{"id":6841742,"accession":"0000899243-22-035274","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-035274","line_url":"/filing/0000899243-22-035274#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Kutzkey Tim; Ponoi Management, LLC; COLUMN GROUP II, LP; Svennilson Peter; PONOI CAPITAL, LP; COLUMN GROUP L P; Ponoi Capital II, LP; Ponoi II Management, LLC; Column Group Management LP; Column Group II GP, LP","owner_display_name":"Kutzkey Tim","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":104090.0,"shares_display":"104,090","price_per_share":4.9871,"price_display":"4.99","price_state":"stated","total_value":519107.239,"total_display":"519,107.24","total_whole":"519,107","shares_owned_after":304787.0,"shares_owned_after_display":"304,787","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-03","filed_date":"2022-11-07","scope":"insider"},{"id":6089886,"accession":"0000899243-22-034559","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-034559","line_url":"/filing/0000899243-22-034559#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Ponoi II Management, LLC; Kutzkey Tim; Column Group II GP, LP; Column Group Management LP; COLUMN GROUP L P; Ponoi Capital II, LP; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi Management, LLC; Svennilson Peter","owner_display_name":"Ponoi II Management, LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":76877.0,"shares_display":"76,877","price_per_share":4.8602,"price_display":"4.86","price_state":"stated","total_value":373637.5954,"total_display":"373,637.60","total_whole":"373,638","shares_owned_after":200697.0,"shares_owned_after_display":"200,697","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-27","filed_date":"2022-10-31","scope":"insider"},{"id":6878343,"accession":"0000899243-22-034352","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-034352","line_url":"/filing/0000899243-22-034352#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Kutzkey Tim; Ponoi Management, LLC; Ponoi Capital II, LP; COLUMN GROUP L P; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi II Management, LLC; Column Group II GP, LP; Column Group Management LP; Svennilson Peter","owner_display_name":"Kutzkey Tim","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":72774.0,"shares_display":"72,774","price_per_share":4.8512,"price_display":"4.85","price_state":"stated","total_value":353041.2288,"total_display":"353,041.23","total_whole":"353,041","shares_owned_after":123820.0,"shares_owned_after_display":"123,820","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-26","filed_date":"2022-10-27","scope":"insider"},{"id":6878339,"accession":"0000899243-22-034352","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-034352","line_url":"/filing/0000899243-22-034352#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Kutzkey Tim; Ponoi Management, LLC; Ponoi Capital II, LP; COLUMN GROUP L P; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi II Management, LLC; Column Group II GP, LP; Column Group Management LP; Svennilson Peter","owner_display_name":"Kutzkey Tim","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51046.0,"shares_display":"51,046","price_per_share":4.7484,"price_display":"4.75","price_state":"stated","total_value":242386.8264,"total_display":"242,386.83","total_whole":"242,387","shares_owned_after":51046.0,"shares_owned_after_display":"51,046","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-25","filed_date":"2022-10-27","scope":"insider"},{"id":6235842,"accession":"0000899243-22-022212","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-022212","line_url":"/filing/0000899243-22-022212","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Svennilson Peter; Ponoi II Management, LLC; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi Capital II, LP; COLUMN GROUP L P; Kutzkey Tim; Column Group II GP, LP; Ponoi Management, LLC; Column Group Management LP","owner_display_name":"Svennilson Peter","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":984161.0,"shares_display":"984,161","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":13286173.5,"total_display":"13,286,173.50","total_whole":"13,286,174","shares_owned_after":2650177.0,"shares_owned_after_display":"2,650,177","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-09","filed_date":"2022-06-13","scope":"insider","n_lines":2},{"id":6291058,"accession":"0000899243-22-021215","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-021215","line_url":"/filing/0000899243-22-021215","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"PONOI CAPITAL, LP; Ponoi Management, LLC; Column Group II GP, LP; Ponoi II Management, LLC; Kutzkey Tim; Ponoi Capital II, LP; COLUMN GROUP II, LP; Column Group Management LP; COLUMN GROUP L P; Svennilson Peter","owner_display_name":"PONOI CAPITAL, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34200.0,"shares_display":"34,200","price_per_share":13.0333,"price_display":"13.03","price_state":"stated","total_value":445738.86,"total_display":"445,738.86","total_whole":"445,739","shares_owned_after":1698493.0,"shares_owned_after_display":"1,698,493","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-06","scope":"insider","n_lines":2},{"id":6117509,"accession":"0000899243-22-020688","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-020688","line_url":"/filing/0000899243-22-020688","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group II GP, LP; Column Group Management LP; Ponoi Management, LLC; Svennilson Peter; Kutzkey Tim; Ponoi II Management, LLC; PONOI CAPITAL, LP; COLUMN GROUP L P; Ponoi Capital II, LP; COLUMN GROUP II, LP","owner_display_name":"Column Group II GP, LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":92000.0,"shares_display":"92,000","price_per_share":13.45,"price_display":"13.45","price_state":"stated","total_value":1237400.0,"total_display":"1,237,400.00","total_whole":"1,237,400","shares_owned_after":1665422.0,"shares_owned_after_display":"1,665,422","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-02","scope":"insider","n_lines":2},{"id":6117503,"accession":"0000899243-22-020688","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-020688","line_url":"/filing/0000899243-22-020688","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group II GP, LP; Column Group Management LP; Ponoi Management, LLC; Svennilson Peter; Kutzkey Tim; Ponoi II Management, LLC; PONOI CAPITAL, LP; COLUMN GROUP L P; Ponoi Capital II, LP; COLUMN GROUP II, LP","owner_display_name":"Column Group II GP, LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":61806.0,"shares_display":"61,806","price_per_share":13.4658,"price_display":"13.47","price_state":"stated","total_value":832267.2348,"total_display":"832,267.23","total_whole":"832,267","shares_owned_after":1576458.0,"shares_owned_after_display":"1,576,458","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-31","filed_date":"2022-06-02","scope":"insider","n_lines":2},{"id":6364761,"accession":"0000899243-22-020202","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-020202","line_url":"/filing/0000899243-22-020202","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Ponoi Management, LLC; Kutzkey Tim; PONOI CAPITAL, LP; COLUMN GROUP II, LP; Ponoi II Management, LLC; Column Group Management LP; Ponoi Capital II, LP; COLUMN GROUP L P; Column Group II GP, LP; Svennilson Peter","owner_display_name":"Ponoi Management, LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2710.0,"shares_display":"2,710","price_per_share":13.4513,"price_display":"13.45","price_state":"stated","total_value":36453.023,"total_display":"36,453.02","total_whole":"36,453","shares_owned_after":1516692.0,"shares_owned_after_display":"1,516,692","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-05-31","scope":"insider","n_lines":2},{"id":6364759,"accession":"0000899243-22-020202","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-020202","line_url":"/filing/0000899243-22-020202","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Ponoi Management, LLC; Kutzkey Tim; PONOI CAPITAL, LP; COLUMN GROUP II, LP; Ponoi II Management, LLC; Column Group Management LP; Ponoi Capital II, LP; COLUMN GROUP L P; Column Group II GP, LP; Svennilson Peter","owner_display_name":"Ponoi Management, LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20201.0,"shares_display":"20,201","price_per_share":13.4935,"price_display":"13.49","price_state":"stated","total_value":272582.1935,"total_display":"272,582.19","total_whole":"272,582","shares_owned_after":1514071.0,"shares_owned_after_display":"1,514,071","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-26","filed_date":"2022-05-31","scope":"insider","n_lines":2},{"id":6914379,"accession":"0000899243-22-019937","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-019937","line_url":"/filing/0000899243-22-019937","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Kutzkey Tim; Column Group LLC; Ponoi II Management, LLC; Svennilson Peter; Ponoi Management, LLC; Column Group II GP, LP; COLUMN GROUP II, LP; GOEDDEL DAVID V; PONOI CAPITAL, LP; Ponoi Capital II, LP","owner_display_name":"Kutzkey Tim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1900.0,"shares_display":"1,900","price_per_share":12.4549,"price_display":"12.45","price_state":"stated","total_value":23664.31,"total_display":"23,664.31","total_whole":"23,664","shares_owned_after":1236261.0,"shares_owned_after_display":"1,236,261","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-27","scope":"insider","n_lines":2},{"id":6691292,"accession":"0000899243-22-019689","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-019689","line_url":"/filing/0000899243-22-019689","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP II, LP; Ponoi II Management, LLC; Ponoi Capital II, LP; COLUMN GROUP L P; PONOI CAPITAL, LP; Svennilson Peter; Ponoi Management, LLC; Kutzkey Tim; Column Group Management LP; Column Group II GP, LP","owner_display_name":"COLUMN GROUP II, LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43292.0,"shares_display":"43,292","price_per_share":13.4349,"price_display":"13.43","price_state":"stated","total_value":581623.6908,"total_display":"581,623.69","total_whole":"581,624","shares_owned_after":1494537.0,"shares_owned_after_display":"1,494,537","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-26","scope":"insider","n_lines":2},{"id":6803762,"accession":"0000899243-22-019470","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-019470","line_url":"/filing/0000899243-22-019470","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Svennilson Peter; Ponoi Capital II, LP; PONOI CAPITAL, LP; GOEDDEL DAVID V; Ponoi Management, LLC; Kutzkey Tim; Column Group LLC; Column Group II GP, LP; COLUMN GROUP II, LP; Ponoi II Management, LLC","owner_display_name":"Svennilson Peter","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16314.0,"shares_display":"16,314","price_per_share":12.0021,"price_display":"12.00","price_state":"stated","total_value":195802.2594,"total_display":"195,802.26","total_whole":"195,802","shares_owned_after":1234424.0,"shares_owned_after_display":"1,234,424","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-25","scope":"insider","n_lines":2},{"id":6691288,"accession":"0000899243-22-019689","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-019689","line_url":"/filing/0000899243-22-019689","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP II, LP; Ponoi II Management, LLC; Ponoi Capital II, LP; COLUMN GROUP L P; PONOI CAPITAL, LP; Svennilson Peter; Ponoi Management, LLC; Kutzkey Tim; Column Group Management LP; Column Group II GP, LP","owner_display_name":"COLUMN GROUP II, LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17828.0,"shares_display":"17,828","price_per_share":13.368,"price_display":"13.37","price_state":"stated","total_value":238324.704,"total_display":"238,324.70","total_whole":"238,325","shares_owned_after":1452674.0,"shares_owned_after_display":"1,452,674","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-26","scope":"insider","n_lines":2},{"id":6803752,"accession":"0000899243-22-019470","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-019470","line_url":"/filing/0000899243-22-019470","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Svennilson Peter; Ponoi Capital II, LP; PONOI CAPITAL, LP; GOEDDEL DAVID V; Ponoi Management, LLC; Kutzkey Tim; Column Group LLC; Column Group II GP, LP; COLUMN GROUP II, LP; Ponoi II Management, LLC","owner_display_name":"Svennilson Peter","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10236.0,"shares_display":"10,236","price_per_share":12.4993,"price_display":"12.50","price_state":"stated","total_value":127942.8348,"total_display":"127,942.83","total_whole":"127,943","shares_owned_after":1218648.0,"shares_owned_after_display":"1,218,648","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-05-25","scope":"insider","n_lines":2},{"id":6200310,"accession":"0000899243-22-019208","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-019208","line_url":"/filing/0000899243-22-019208","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group II GP, LP; COLUMN GROUP II, LP; Column Group Management LP; Ponoi Capital II, LP; COLUMN GROUP L P; Svennilson Peter; PONOI CAPITAL, LP; Ponoi Management, LLC; Kutzkey Tim; Ponoi II Management, LLC","owner_display_name":"Column Group II GP, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19034.0,"shares_display":"19,034","price_per_share":13.4776,"price_display":"13.48","price_state":"stated","total_value":256532.6384,"total_display":"256,532.64","total_whole":"256,533","shares_owned_after":1435434.0,"shares_owned_after_display":"1,435,434","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-23","scope":"insider","n_lines":2},{"id":6200302,"accession":"0000899243-22-019208","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-019208","line_url":"/filing/0000899243-22-019208","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group II GP, LP; COLUMN GROUP II, LP; Column Group Management LP; Ponoi Capital II, LP; COLUMN GROUP L P; Svennilson Peter; PONOI CAPITAL, LP; Ponoi Management, LLC; Kutzkey Tim; Ponoi II Management, LLC","owner_display_name":"Column Group II GP, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20666.0,"shares_display":"20,666","price_per_share":13.2547,"price_display":"13.25","price_state":"stated","total_value":273921.6302,"total_display":"273,921.63","total_whole":"273,922","shares_owned_after":1417028.0,"shares_owned_after_display":"1,417,028","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-23","scope":"insider","n_lines":2},{"id":6974154,"accession":"0000899243-22-018848","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-018848","line_url":"/filing/0000899243-22-018848","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Ponoi II Management, LLC; PONOI CAPITAL, LP; Column Group Management LP; COLUMN GROUP II, LP; Ponoi Capital II, LP; COLUMN GROUP L P; Svennilson Peter; Ponoi Management, LLC; Kutzkey Tim; Column Group II GP, LP","owner_display_name":"Ponoi II Management, LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":62650.0,"shares_display":"62,650","price_per_share":13.2039,"price_display":"13.20","price_state":"stated","total_value":827224.335,"total_display":"827,224.34","total_whole":"827,224","shares_owned_after":1397044.0,"shares_owned_after_display":"1,397,044","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-19","scope":"insider","n_lines":2},{"id":6974143,"accession":"0000899243-22-018848","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-018848","line_url":"/filing/0000899243-22-018848","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Ponoi II Management, LLC; PONOI CAPITAL, LP; Column Group Management LP; COLUMN GROUP II, LP; Ponoi Capital II, LP; COLUMN GROUP L P; Svennilson Peter; Ponoi Management, LLC; Kutzkey Tim; Column Group II GP, LP","owner_display_name":"Ponoi II Management, LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":89049.0,"shares_display":"89,049","price_per_share":13.4171,"price_display":"13.42","price_state":"stated","total_value":1194779.3379,"total_display":"1,194,779.34","total_whole":"1,194,779","shares_owned_after":1336461.0,"shares_owned_after_display":"1,336,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-19","scope":"insider","n_lines":2},{"id":6741244,"accession":"0000899243-22-018399","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-018399","line_url":"/filing/0000899243-22-018399","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Ponoi II Management, LLC; Svennilson Peter; COLUMN GROUP L P; Ponoi Capital II, LP; Column Group Management LP; PONOI CAPITAL, LP; Kutzkey Tim; Column Group II GP, LP; COLUMN GROUP II, LP; Ponoi Management, LLC","owner_display_name":"Ponoi II Management, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33166.0,"shares_display":"33,166","price_per_share":12.9015,"price_display":"12.90","price_state":"stated","total_value":427891.149,"total_display":"427,891.15","total_whole":"427,891","shares_owned_after":1250351.0,"shares_owned_after_display":"1,250,351","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-17","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2022-05-16|6741241","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001426332","name":"NGM BIOPHARMACEUTICALS INC","url":"/issuer/0001426332","role":"Ten percent owner, Other","n_filings":62,"first_seen":"2019-04-10","last_seen":"2023-11-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001673772","name":"RAPT Therapeutics, Inc.","url":"/issuer/0001673772","role":"Ten percent owner, Other","n_filings":11,"first_seen":"2019-11-04","last_seen":"2022-05-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001437786","name":"Immune Design Corp.","url":"/issuer/0001437786","role":"Ten percent owner","n_filings":2,"first_seen":"2016-09-22","last_seen":"2017-10-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001645333","retrieved_at":"2026-08-23T02:00:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}